Skip to content
Loading company
Loading

Latest quarter · Q2 FY2012

Millions
Total revenues
13
Operating income
(8)
Net income
(8)
Open Financials

ALLOS THERAPEUTICS INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2011FY2010ChangeSource
Revenue$76 million$35.2 million+115.9%10-K 2012-03-26 · proof
Operating income-$30.6 million-$79 million10-K 2012-03-26 · proof
Net income-$30.5 million-$77.4 million10-K 2012-03-26 · proof
Cash from operating activities-$752,000-$63.7 million10-K 2012-03-26 · proof
Total assets$122.1 million$120.8 million+1.1%10-K 2012-03-26 · proof
Total liabilities$42.8 million$22.6 million+89.6%10-K 2012-03-26 · proof
Cash and cash equivalents$87.4 million$48.2 million+81.4%10-K 2012-03-26 · proof
What was ALLOS THERAPEUTICS INC's revenue in fiscal 2011?
ALLOS THERAPEUTICS INC reported revenue of $76 million for fiscal 2011 (the year ended Dec 31, 2011), against $35.2 million the year before (+115.9%). Source: the 10-K filed with the SEC on Mar 26, 2012. SEC
What was ALLOS THERAPEUTICS INC's operating income in fiscal 2011?
ALLOS THERAPEUTICS INC reported operating income of -$30.6 million for fiscal 2011 (the year ended Dec 31, 2011), against -$79 million the year before. Source: the 10-K filed with the SEC on Mar 26, 2012. SEC
What was ALLOS THERAPEUTICS INC's net income in fiscal 2011?
ALLOS THERAPEUTICS INC reported net income of -$30.5 million for fiscal 2011 (the year ended Dec 31, 2011), against -$77.4 million the year before. Source: the 10-K filed with the SEC on Mar 26, 2012. SEC
What was ALLOS THERAPEUTICS INC's cash from operating activities in fiscal 2011?
ALLOS THERAPEUTICS INC reported cash from operating activities of -$752,000 for fiscal 2011 (the year ended Dec 31, 2011), against -$63.7 million the year before. Source: the 10-K filed with the SEC on Mar 26, 2012. SEC
What are ALLOS THERAPEUTICS INC's total assets?
As of Dec 31, 2011, ALLOS THERAPEUTICS INC reported total assets of $122.1 million, against $120.8 million a year earlier (+1.1%). Source: the 10-K filed with the SEC on Mar 26, 2012. SEC
What are ALLOS THERAPEUTICS INC's total liabilities?
As of Dec 31, 2011, ALLOS THERAPEUTICS INC reported total liabilities of $42.8 million, against $22.6 million a year earlier (+89.6%). Source: the 10-K filed with the SEC on Mar 26, 2012. SEC
What are ALLOS THERAPEUTICS INC's cash and cash equivalents?
As of Dec 31, 2011, ALLOS THERAPEUTICS INC reported cash and cash equivalents of $87.4 million, against $48.2 million a year earlier (+81.4%). Source: the 10-K filed with the SEC on Mar 26, 2012. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1097264&period_type=annual&limit=5"

Information only, not investment advice.